IncFact
Company Profiles: Revenue, Growth, Competition

Stemexpress Revenue, Growth & Competitor Profile

DBA CGT GLOBAL
Last updated:

Company Awards

Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Stemexpress

Access the complete profile.

Stemexpress Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry621511 Medical Laboratories
Address1743 Creekside Drive, Suite 200
Folsom, CA 95630

Note: Revenues for privately held companies are statistical evaluations.


Stemexpress's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Stemexpress is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Stemexpress Annual Revenue and Growth Rate

Stemexpress Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $10 - $100 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Stemexpress's revenues are gauged from an analysis of company filings.



Stemexpress's Income Statement (based on Industry Averages)

Stemexpress P&L$ Millions
Revenue (Sales) Stemexpress Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Stemexpress is developing and marketing. Stemexpress doesn't have any recent trademark applications, indicating Stemexpress is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
LEUKOPAK
Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use
10/11/2016
STEMEXPRESS ADVANCING SCIENCE
Biological tissue, namely, stem cells, human primary cells, blood and bone marrow for use in scientific and medical research
07/11/2016
ADVANCING SCIENCE
Biological tissue, namely, stem cells, human primary cells, blood and bone marrow for use in scientific and medical research
03/28/2016

See all trademarks and details in the Full Report.


Market Share of Stemexpress's Largest Competitors

A competitive analysis shows these companies are in the same general field as Stemexpress, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORYBurbank, CA100 
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITYLinden, NJ100 
CENTOGENE USCambridge, MA88 
LATARA ENTERPRISEPomona, CA61 
TELIGENT PHARMAVineland, NJ46 
COVID CLINICHuntington Beach, CA37 
VIKOR SCIENTIFICCharleston, SC33 
BIOTHERANOSTICSSan Diego, CA31 
SHERMAN-ABRAMS LABORATORYBrooklyn, NY31 




Nearby Competitors

These companies are similar in business line and location to Stemexpress. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
STEMEXPRESSFolsom, CA100 
GEMINI BIOPRODUCTSWest Sacramento, CA89 
CIANNA MEDICALAliso Viejo, CA59 
NUTRISHAREElk Grove, CA27 
HEMOSTAT LABORATORIESDixon, CA21 
QUANTUM NEUROMONITORING CORPORATION A MEDICALFolsom, CA11 




Future Competition: Stemexpress's Fastest Growing Competitors

These companies are in the same general field as Stemexpress and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Stemexpress Competitors